Navigation Links
MedAptus Secures $6 Million Investment
Date:3/19/2009

Funding to Support Increasing Sales of the Company's Innovative Revenue Cycle Offerings

BOSTON, March 19 /PRNewswire/ -- MedAptus(R), market leader for charge capture technologies, today announced that it has secured $6 million in capital in a financing led by existing investor Boston Millennia Partners. This investment will enable MedAptus to further support the growth of its Intelligent Charge Capture suite of products.

"The realities of today's economy require provider organizations to look at financial performance more closely than ever," said MedAptus CEO Dennis Mitchell. "This means that our offerings have become must-have for hospitals and physician practices in order to grow and thrive. This financing will allow us to innovate in ways that drive unparalleled revenue integrity and optimization for our customers."

MedAptus' powerful, yet easy-to-use, electronic charge capture technologies are practice-proven to maximize revenue, enhance compliance efforts and increase billing process transparency. Offerings include solutions for professional, facility and infusion services coding and billing, as well as complementary modules for PQRI and other clinically oriented tasks. Thousands of clinicians across organizations that include single-specialty practices, multi-specialty groups and large academic institutions use MedAptus on a daily basis.

"We are quite proud of the success MedAptus has experienced with its physician solution. Also, the company's Facility Charge Capture product, the first of its kind for the ambulatory environment, is a tremendously appealing product, particularly given the increasing economic challenges facing hospitals," said Robert Jevon, partner at Boston Millennia Partners and a member of the MedAptus Board of Directors. "Lots of people are talking about the inefficient processes that plague healthcare -- we're delighted that MedAptus is actually doing something about it."

About MedAptus

MedAptus is the Gold Standard in the healthcare revenue cycle for effective charge management, compliance and workflow efficiency. With the most powerful, yet easy-to-use, Intelligent Charge Capture technologies available, we enjoy enterprise-wide adoption at some of the nation's most prestigious healthcare organizations. Our portfolio of full-scale Professional and Facility offerings is practice-proven to increase revenue, re-engineer archaic processes, enhance EMR investments and save busy providers valuable time. For more information, visit http://www.medaptus.com or call 617.896.4000.

    MedAptus Contact:

    Jennifer Crowley
    p. 617.896.4030
    jcrowley@medaptus.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE MedAptus
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedAptus Experiences Record Growth of 70 Percent
2. MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology
3. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
4. Still River Systems, Inc. Secures $33 Million in Private Financing
5. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
6. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
7. Noteworthy Medical Systems, Inc. Secures Capital from Top European eHealth Provider and Closes on Merger with Strategic Partner
8. Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries
9. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
10. Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
11. Stuart M. Goldstein, Southern New Jersey Patent and Intellectual Property Attorney, secures a New Revolutionary Eco-Friendly Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: